Bioactive Compounds
-
BA2296 LY1Summary: LY1 is a potent and selective covalent inhibitor against and. -
N2012 Pulchinenoside B -
BA2295 SARS-CoV-2-IN-39Summary: SARS-CoV-2-IN-39 (compound 21) is an inhibitor. -
N1959 Trifolirhizin;(-)-Maackiain-3-O-glucoside -
BA2294 SARS-CoV-2-IN-7Summary: SARS-CoV-2-IN-7 in SARS-CoV-2-infected VeroE6 cells in nanomoles. -
N1902 Ononin -
BA2293 SARS-CoV-2-IN-13Summary: SARS-CoV-2-IN-13 is a potent inhibitor. -
N1901 LigustilideSummary: facilitates blood circulation and attenuates inflammatory pain behavior -
BA2292 SARS-CoV-2-IN-6Summary: SARS-CoV-2-IN-6 is an inhibitor that shows potent enzyme inhibitory activity. -
BA2291 HCoV-229E-IN-1Summary: HCoV-229E-IN-1 is a potent inhibitor of replication.
